Dr. Omenn’s research interests lie in clinical and biomedical informatics and cancer proteomics. He has long-standing interests in mechanisms of genetic predispositions to risks from environmental and occupational exposures, pharmacogenetics and pharmacogenomics, and science-based risk analyses. He is an elected member of the National Academy of Medicine.
- M.D., Harvard University
- Ph.D., Genetics, University of Washington
- B.A., Princeton University